Dusilová, T.; Kovář, J.; Laňková, I.; Thieme, L.; Hubáčková, M.; Šedivý, P.; Pajuelo, D.; Burian, M.; Dezortová, M.; Miklánková, D.;
et al. Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD). J. Clin. Med. 2024, 13, 6100.
https://doi.org/10.3390/jcm13206100
AMA Style
Dusilová T, Kovář J, Laňková I, Thieme L, Hubáčková M, Šedivý P, Pajuelo D, Burian M, Dezortová M, Miklánková D,
et al. Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD). Journal of Clinical Medicine. 2024; 13(20):6100.
https://doi.org/10.3390/jcm13206100
Chicago/Turabian Style
Dusilová, Tereza, Jan Kovář, Ivana Laňková, Lenka Thieme, Monika Hubáčková, Petr Šedivý, Dita Pajuelo, Martin Burian, Monika Dezortová, Denisa Miklánková,
and et al. 2024. "Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD)" Journal of Clinical Medicine 13, no. 20: 6100.
https://doi.org/10.3390/jcm13206100
APA Style
Dusilová, T., Kovář, J., Laňková, I., Thieme, L., Hubáčková, M., Šedivý, P., Pajuelo, D., Burian, M., Dezortová, M., Miklánková, D., Malínská, H., Svobodová Šťastná, P., Poledne, R., Hájek, M., & Haluzík, M.
(2024). Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD). Journal of Clinical Medicine, 13(20), 6100.
https://doi.org/10.3390/jcm13206100
